GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (BOM:524816) » Definitions » Dividend Payout Ratio

Natco Pharma (BOM:524816) Dividend Payout Ratio : 0.06 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Dividend Payout Ratio?

Natco Pharma's dividend payout ratio for the months ended in Mar. 2024 was 0.06.

The historical rank and industry rank for Natco Pharma's Dividend Payout Ratio or its related term are showing as below:

BOM:524816' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.18   Max: 0.55
Current: 0.13


During the past 13 years, the highest Dividend Payout Ratio of Natco Pharma was 0.55. The lowest was 0.11. And the median was 0.18.

BOM:524816's Dividend Payout Ratio is ranked better than
88.5% of 426 companies
in the Drug Manufacturers industry
Industry Median: 0.335 vs BOM:524816: 0.13

As of today (2024-05-28), the Dividend Yield % of Natco Pharma is 0.92%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Natco Pharma was 1.50%. The lowest was 0.17%. And the median was 0.72%.

Natco Pharma's Dividends per Share for the months ended in Mar. 2024 was ₹1.25.

During the past 12 months, Natco Pharma's average Dividends Per Share Growth Rate was 52.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -7.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -6.80% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 24.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Natco Pharma was 102.10% per year. The lowest was -8.80% per year. And the median was 17.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Natco Pharma Dividend Payout Ratio Historical Data

The historical data trend for Natco Pharma's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Dividend Payout Ratio Chart

Natco Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.27 0.55 0.14 0.12

Natco Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 - 0.34 0.11 0.06

Competitive Comparison of Natco Pharma's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natco Pharma's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Natco Pharma's Dividend Payout Ratio falls into.



Natco Pharma Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Natco Pharma's Dividend Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2024 )/ EPS without NRI (A: Mar. 2024 )
=9.5/ 77.34
=0.12

Natco Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=1.25/ 21.56
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Natco Pharma (BOM:524816) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Natco Pharma Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Natco Pharma's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Natco Pharma (BOM:524816) Business Description

Traded in Other Exchanges
Address
Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (BOM:524816) Headlines

No Headlines